Why the study?
Cardiovascular disease is the leading cause of death in NAFLD patients, prompting a detailed evaluation of the relationship and underlying pathophysiological mechanisms between NAFLD and coronary heart disease.
Is non-alcoholic fatty liver disease associated with the development and severity of coronary heart disease?
Is non-alcoholic fatty liver disease associated with the development and severity of coronary heart disease?
NAFLD is an independent risk factor for the development, severity, and poor prognosis of coronary heart disease, highlighting the need for cardiovascular risk assessment in these patients.
Answers are grounded in this paper and cite their sources.
NAFLD independently raises CHD risk beyond metabolic factors; leaves open whether liver-targeted interventions improve CV outcomes.
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease and considered a liver manifestation of metabolic syndrome. It is in close relationship with insulin resistance, obesity, diabetes mellitus, all of which increase risk of cardiovascular disease (CVD). Besides, many studies point out that NAFLD independently contributes to the development of atherosclerosis and CHD. On the other hand, CVDs are the leading cause of death in NAFLD patients. Many pathophysiological changes and molecular mechanisms play an important role in NAFLD for CVD formation. Atherosclerosis is common in NAFLD, which also mainly contributes to the CVD formation and CHD. Many studies linking atherosclerotic CHD and NAFLD are present in the literature. Subclinical CHD, mainly detected by coronary computed tomography views, have been detected more common in NAFLD patients. Presence of NAFLD has been found to be more common in patients with severe CHD and in stable CHD, NAFLD has been found to be associated with more diffuse disease. In acute coronary syndromes, especially in acute myocardial infarction, patients with NAFLD have been found to have poor prognosis when compared with NAFLD free patients. In this review, our aim is to evaluate the relationship between NAFLD and CHD in detail and go over the pathophysiological mechanisms underlying this relationship.
No takes yet. Share an insight, caveat, or question.
Arslan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: